ArticleMolecular neurobiology2026
TLR2 Regulates α-Synuclein Phosphorylation and Release in an Enteroendocrine Cell Model.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is characterized by the progressive accumulation and prion-like spread of pathological α-synuclein (α-syn). Increasing evidence suggests that α-syn pathology may originate in the gastrointestinal tract before spreading to the central nervous system; however, the intestinal mechanisms that initiate pathological α-syn phosphorylation and intercellular transfer remain poorly understood. Here, we investigated the role of Toll-like receptor 2 (TLR2) in regulating α-syn phosphorylation using intestinal epithelial cell model. We found that pSer129-positive α-syn immunoreactivity and TLR2 expression progressively increased in the mouse jejunum during aging. Although pSer129-positive structures did not substantially colocalize with chromogranin A-positive enteroendocrine cells, we confirmed that TLR2 is expressed in a subset of these cells in vivo. Furthermore, analysis of single-cell transcriptomic data from mouse enteroendocrine cells and human colonic organoids revealed that a small subset of enteroendocrine cells express TLR2. We therefore used the enteroendocrine cell line STC-1 as an in vitro model to investigate TLR2-dependent α-syn phosphorylation in an enteroendocrine-like context. In STC-1 cells, TLR2 enhanced the cellular uptake of extracellular α-syn preformed fibrils (PFFs), promoted the generation of pSer129 α-syn and higher molecular weight α-syn species, and facilitated the extracellular release of factors that increased pSer129 immunoreactivity in recipient cells. Pharmacological inhibition of TLR2 attenuated PFF uptake and pSer129 α-syn generation. Conditioned medium from TLR2-overexpressing STC-1 cells increased pSer129 α-syn immunoreactivity in recipient neuronal cells, suggesting that TLR2 may promote the release of soluble factors capable of inducing α-syn phosphorylation in recipient cells. The molecular identity of the transferred factor(s) and the underlying mechanism remain to be determined. Collectively, our findings identify TLR2 as a regulator of α-syn uptake, phosphorylation, and release in an enteroendocrine cell model. These results support a potential role for aging-associated upregulation of intestinal TLR2 in modulating α-syn phosphorylation, although the in vivo cellular source of pSer129 α-syn and the contribution of enteroendocrine cells require further investigation.
Indexed as
Identifiers
42747668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.